BioMarin Pharmaceutical Inc. ( BMRN) - Key Metrics
BMRN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $4.56 | -$0.24 | $0.52 | $0.31 |
| 2025Q3 | $4.04 | -$0.16 | $1.92 | $1.77 |
| 2025Q2 | $4.31 | $1.26 | $0.97 | $0.88 |
| 2025Q1 | $3.90 | $0.97 | $0.91 | $0.83 |
BMRN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -61.18 |
| 2025Q3 | ? | -84.57 |
| 2025Q2 | ? | 10.94 |
| 2025Q1 | ? | 18.18 |
BMRN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.84% | ? |
| 2025Q4 | 0.52% | ? |
| 2025Q3 | 3.27% | ? |
| 2025Q2 | 1.60% | ? |
| 2025Q1 | 1.17% | ? |
BMRN
Price: $55.26
52 week price:
Earnings Per Share: 1.39 USD
P/E Ratio: 38.89
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Ebitda: 11.0 millionMarket Capitalization: 10.9 billion